Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Organigram Holdings, Inc. (OTC: OGRMF).

Full DD Report for OGRMF

You must become a subscriber to view this report.


Recent News from (OTC: OGRMF)

Organigram Receives Permit to Export Medical Cannabis to Australia
Organigram Receives Permit to Export Medical Cannabis to Australia Canada NewsWire MONCTON, NB, May 17, 2018 Company Continues to Build International Presence Leveraging Award-Winning, High-Quality Product MONCTON, NB , May 17, 2018 /CNW/ - Organigram Holdings Inc. (T...
Source: Canada Newswire
Date: May, 17 2018 06:00
NYC sees marijuana revenue stream
New York state would gain $435.7M annually in tax revenue for legalized weed, while New York City would get about $336M, according to NYC Comptroller Scott Stringer. More news on: Aurora Cannabis Inc., Aero Grow International, Inc., American Cannabis Company, Inc., Read more ......
Source: SeekingAlpha
Date: May, 17 2018 04:56
Cannabis Is Fueling The Next Era of Medical Revolution
Palm Beach FL – May 16, 2018 – Talk of legalizing marijuana throughout North America has been growing like a weed. Up to 88% of Americans favor its medicinal use, thanks to a growing body of research supporting marijuana’s use for medical purposes.  Some studies even su...
Source: MarketNewsUpdates.com
Date: May, 16 2018 08:02
Weekly Cannabis Report: Aurora/MedReleaf, Canopy, Maricann
Welcome to our Weekly Cannabis Report, a reliable source for cannabis investors to receive the latest developments and analysis. Weekly Note to Readers The cannabis sector saw its biggest acquisition to-date when Aurora (ACBFF) finally announced the acquisition of MedReleaf (MEDFF) for a h...
Source: SeekingAlpha
Date: May, 15 2018 10:20
Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada
Organigram Announces Receipt of License for Controlled Drugs and Substances from Health Canada Canada NewsWire MONCTON, NB, May 15, 2018 "Dealer's License" will permit greater research and development opportunities for new products and formulations MONCTON, NB , May 15...
Source: Canada Newswire
Date: May, 15 2018 06:00
Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands
Organigram Unveils Comprehensive Suite of Adult Recreational Cannabis Brands Canada NewsWire MONCTON, NB, May 15, 2018 Consumer preferences, authenticity and segmentation at heart of industry-leading brand portfolio MONCTON, NB , May 15, 2018 /CNW/ - Organigram ...
Source: Canada Newswire
Date: May, 15 2018 06:00
5 of Today's Biggest Marijuana Stock Gainers - Monday, May 14th
Out of over 200+ marijuana stocks , here are 5 of the biggest marijuana stock winners in trading on Monday, May 14th including Canopy Growth Corp. (TSX:WEED) (OTC:TWMJF) and more... Canopy Growth Corp. (TSX:WEED) (OTC:TWMJF) Shares of Canopy Growth Corp. rose 6.49% on higher than averag...
Source: Daily Marijuana Observer
Date: May, 14 2018 17:36
Grow Your Portfolio: Invest In The Growing Cannabis Industry
Thirty U.S. states have legalized cannabis in some form, and Canada is poised to become the first industrialized nation to legalize recreational use this summer. Worldwide sentiment about cannabis has changed, and it no longer has as much of the stigma as it has in the past. This is a good si...
Source: Pot News
Date: May, 10 2018 03:42
OrganiGram Holdings: This May Be The Most Undervalued Company In The Cannabis Industry
Source: Newswire The cannabis industry at this time can't be considered one that investors are looking for earnings results in the near term, as the producers battle it out to raise production levels in order to secure their positions in the battle for market share. While most competitor...
Source: SeekingAlpha
Date: May, 09 2018 11:44
Weekly Cannabis Report: MedReleaf Sell, TGOD IPO, Loblaw Wins
Welcome to our Weekly Cannabis Report, a reliable source for cannabis investors to receive the latest developments and analysis. Weekly Note to Readers There are three things that cannabis investors need to know from last week. Fourth-largest Canadian cannabis company MedReleaf is reported...
Source: SeekingAlpha
Date: May, 08 2018 15:20

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-08-173.863.853.913.76225,430
2018-08-163.8353.80983.93963.73326,735
2018-08-153.743.893.94153.53410,111
2018-08-143.743.493.743.48370,769
2018-08-133.823.703.823.54340,269

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-17142,979236,21660.5289Short
2018-08-16195,492329,00559.4192Short
2018-08-15233,705432,29154.0620Short
2018-08-14150,361370,76940.5538Short
2018-08-13152,612340,26944.8504Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on OGRMF.


About Organigram Holdings, Inc. (OTC: OGRMF)

Logo for Organigram Holdings, Inc. (OTC: OGRMF)

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram s facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.

 

 

 

Current Management

  • Gregory Engel / CEO
    • Mr. Engel is a senior executive with years of National and International experience in the pharmaceutical, biotechnology, cannabis and consumer packaged goods industries. Mr. Engel has led the creation, development and growth of several companies over the span of his career. An articulate and trusted voice in the burgeoning Canadian cannabis space, Mr. Engel most recently worked with a competitive licensed producer to become the first Canadian exporter of medical cannabis, as well as the establishment of several trailblazing industry standards. As leader at Organigram Inc, Mr. Engel is focused on reputational excellence through product quality and safety, expansion of the company s Moncton, N.B. facility, and production efficiencies to position the company as a leader in the Medical and Adult Recreational Cannabis industries. Mr. Engel graduated from the University of Guelph with an Honours Bachelor of Science in Microbiology.
  • Derrick West / CFO
  • Paolo De Luca / CFO
    • Mr. De Luca joined Organigram on Dec , bringing over years of diversified financial business experience. Mr. De Luca has held senior financial, investor relations, and accounting leadership roles at companies including West Face Capital, one of Canada s leading alternative asset management firms Meridian LNG Potash Ridge C.A. Bancorp and TD Securities
  • Jeff Purcell / VP, Ops.
    • Mr. Purcell assumed the position of Vice President of Operations of Organigram Inc. on June , . He is filling a key role on the company s Senior Leadership Team, as a seasoned professional in the areas of large scale production and facility expansion. Mr. Purcell has the responsibility and oversight for the entire production facility including production, engineering and maintenance, construction, quality assurance, safety, security and the company s vision for oils and extract products. Mr. Purcell brings over years of experience to the role, most recently as Vice President of Operations at Ganong Bros. Limited with responsibilities including implementation of quality systems, safety, and continuous improvement initiatives. While in the role, he was also responsible for a significant facility expansion, essentially creating an entirely new production environment. Prior to Ganong, Mr. Purcell spent over years in progressively senior roles leading operations at McCain Foods. Mr. Purcell holds a Bachelor of Commerce degree, from St. Mary s University.
  • Raymond Gracewood / Chief Commercial Officer
    • As the previous Senior Director of Sales and Marketing for Moosehead Breweries Ltd., Mr. Gracewood is a leading brand and marketing professional in Atlantic Canada. With more than years experience in the marketing space, he is a strong speaker on brand, packaging and positioning, both locally and throughout North America.He has extensive experience in building and developing brands, positioning and segmentation. Mr. Gracewood holds a Bachelor of Business Administration degree, from the University of New Brunswick.
  • Dylan Rogers / Director, Inv. Rel.
  • Denis Arsenault / Executive Chairman
    • Mr. Arsenault has spent the past years as a successful entrepreneur building, running, and selling several profitable businesses. As the former Chief Executive Officer of the Company, Mr. Arsenault focused on growing the Company into a sustainable and successful employer in Moncton. His extensive knowledge and experience in building successful enterprises has helped to establish a strong management team and a modern production facility prior to his transition to the role of Executive Chairman. Mr. Arsenault holds a Bachelor of Administration Degree from the Universite de Moncton
  • Peter Amirault /
    • Mr. Amirault is currently the President of BML Group Limited in Toronto, a holding company with interests in real estate development and private investments. Prior to joining BML Group, Peter held varying executive roles including: President of Swiss Chalet North America for the Cara Group of Companies, CEO of Creemore Springs Brewery Ltd, Senior Vice President of Molson Coors Canada, Managing Director of Sleeman Brewing Ltd, along with senior roles at Nestle Canada and The Premium Beer Company of Toronto. Peter holds a BBA from Acadia University and an MBA from The Schulich School of Business. Peter brings a wealth of knowledge with his previous board experience and roles at senior management levels.
  • Gregory Engel /
    • Mr. Engel is a senior executive with years of National and International experience in the pharmaceutical, biotechnology, cannabis and consumer packaged goods industries. Mr. Engel has led the creation, development and growth of several companies over the span of his career. An articulate and trusted voice in the burgeoning Canadian cannabis space, Mr. Engel most recently worked with a competitive licensed producer to become the first Canadian exporter of medical cannabis, as well as the establishment of several trailblazing industry standards. As leader at Organigram Inc, Mr. Engel is focused on reputational excellence through product quality and safety, expansion of the company s Moncton, N.B. facility, and production efficiencies to position the company as a leader in the Medical and Adult Recreational Cannabis industries. Mr. Engel graduated from the University of Guelph with an Honours Bachelor of Science in Microbiology.
  • Dr. Kenneth Mitton /
    • Dr. Mitton is a highly respected physician practising in Moncton, New Brunswick. Dr. Mitton has practiced medicine for over years as a family doctor. He also advises to a number of large corporations in New Brunswick in respect of occupation health matters. Dr. Mitton has previously served as the Chief of Staff of the SouthEast Regional Health Authority now the Horizon Health Network and is currently the medical director of the Moncton Hospital. Dr. Mitton holds a Bachelor of Science and a Doctor of Medicine Degree from Dalhousie University.
  • Derrick West /

Current Share Structure

  • Market Cap: $418,036,149 - 03/09/2018
  • Issue and Outstanding: 124,526,705 - 01/29/2018

 


Recent Filings from (OTC: OGRMF)

Management Discussion and Analysis - Organigram Holdings Inc MD&A For Quarter Ending Nov 30, 2017
Filing Type: Management Discussion and Analysis - Organigram Holdings Inc MD&A For Quarter Ending Nov 30, 201Filing Source: OTC Markets
Filing Date: February, 23 2018
Quarterly Report - Organigram Holdings Inc Financial Statement for Quarter Ending Nov 30, 2017
Filing Type: Quarterly Report - Organigram Holdings Inc Financial Statement for Quarter Ending Nov 30, 2017Filing Source: OTC Markets
Filing Date: February, 21 2018
Management Discussion and Analysis - MD&A May 31st 2017
Filing Type: Management Discussion and Analysis - MD&A May 31st 2017Filing Source: OTC Markets
Filing Date: July, 31 2017
Quarterly Report - Interim Condensed Consolidated Financial Statements May 31st, 2017
Filing Type: Quarterly Report - Interim Condensed Consolidated Financial Statements May 31st, 2017Filing Source: OTC Markets
Filing Date: July, 31 2017
Management Discussion and Analysis - MD&A February 28 2017
Filing Type: Management Discussion and Analysis - MD&A February 28 2017Filing Source: OTC Markets
Filing Date: May, 29 2017
Interim Financial Report - Interim Condensed Consolidated Financial Statements February 28 2017
Filing Type: Interim Financial Report - Interim Condensed Consolidated Financial Statements February 28 2017Filing Source: OTC Markets
Filing Date: May, 29 2017
Management Discussion and Analysis - MDA November 30, 2016
Filing Type: Management Discussion and Analysis - MDA November 30, 2016Filing Source: OTC Markets
Filing Date: February, 06 2017
Interim Financial Report - Interim Condensed Consolidated Financial Statements November 30, 2016
Filing Type: Interim Financial Report - Interim Condensed Consolidated Financial Statements November 30, 2016Filing Source: OTC Markets
Filing Date: February, 06 2017
Management Discussion and Analysis - MDA August 31, 2016
Filing Type: Management Discussion and Analysis - MDA August 31, 2016Filing Source: OTC Markets
Filing Date: February, 06 2017
Annual Report - Financial Reports
Filing Type: Annual Report - Financial ReportsFiling Source: OTC Markets
Filing Date: February, 06 2017

 

 


Daily Technical Chart for (OTC: OGRMF)

Daily Technical Chart for (OTC: OGRMF)


Stay tuned for daily updates and more on (OTC: OGRMF)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: OGRMF)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in OGRMF is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of OGRMF and does not buy, sell, or trade any shares of OGRMF. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/